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Continued progress in organ donation will help enable
transplantation to alleviate the increasing incidence of
end-stage organ disease. This article discusses the im-
plementation and effect of the federally initiated Organ
Donation Breakthrough Collaborative; it then reviews
organ donation data, living and deceased, from 1995 to
2004. It is the first annual report of the Scientific Reg-
istry of Transplant Recipients to include national data
following initiation of the collaborative in 2003. Prior to
that, annual growth in deceased donation was 2%–4%;
in 2004, after initiation of the collaborative, deceased
donation increased 11%. Identification and dissemina-
tion of best practices for organ donation have empha-
sized new strategies for improved consent, including
revised approaches to minority participation, timing of
requests and team design. The number of organs re-
covered from donation after cardiac death (DCD) grew
from 64 in 1995 to 391 in 2004. While efforts are ongo-
ing to develop methodologies for identifying expanded
criteria donors (ECD) for organs other than kidney, it
is clear DCD and ECD raise questions regarding cost
and recovery. The number of living donor organs in-
creased from 3493 in 1995 to 7002 in 2004; data show
trends toward more living unrelated donors and those
providing non-directed donations.
Note on sources: The articles in this report are based on the ref-
erence tables in the 2005 OPTN/SRTR Annual Report, which are
not included in this publication. Many relevant data appear in the
figures and tables included here; other tables from the Annual Re-
port that serve as the basis for this article include the following:
Tables 1.1, 1.7, 2.1–2.14 and 3.3. All of these tables may be found
online at http://www.ustransplant.org.
Key words: Deceased donors, donation after cardiac
death (DCD), donation service area (DSA), expanded
criteria donors, living donors, organ donation, Organ
Donation Breakthrough Collaborative, organ procure-
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Introduction
Despite remarkable clinical and scientific advances in or-
gan transplantation, organ donation continues to limit trans-
plantation from reaching its full therapeutic potential. To
address this problem, numerous initiatives aimed at im-
proving organ donation have been introduced over the past
decade. Among these are programs to educate the gen-
eral public, improve minority participation, secure the in-
volvement of key medical professionals and assure that
all potential donors are identified and referred in a timely
manner for management by organ donation specialists.
Between 1995 and 2003, these efforts resulted in 2–4%
annual growth in the number of deceased donors. In 2004,
however, a dramatic increase of 11% in deceased do-
nation was seen over the previous year. This 2004 total
of 7152 deceased donors represents the first time that
more than 7000 such donors were realized in a calendar
year and the first time since 2000 that the number of de-
ceased donors outnumbered living donors. These changes
followed closely upon the April 2003 introduction of the Or-
gan Donation Breakthrough Collaborative by the U.S. De-
partment of Health and Human Services (HHS), Health Re-
sources and Services Administration (HRSA). This initiative
represents the most significant commitment by the Fed-
eral Government to improve organ donation since passage
of the Organ Procurement and Transplant Network (OPTN)
Act of 1984. The charge of the collaborative is to identify
the best practices of organ donation in the country and dis-
seminate them rapidly throughout the organ procurement
community.
The effect of these various efforts on organ donation and
future goals can only be determined through rigorous on-
going analysis of national organ donor data. This report re-
views the current organ donation process in the United
States and introduces the Organ Donation Breakthrough
Collaborative. Subsequent sections of this article examine
trends for the past 10 years of consent for donation and
the recovery and disposition of living and deceased donor
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organs. This is the first annual donor report that includes a
full year’s data following the onset of the collaborative.
Unless otherwise indicated, the statistics in this article are
drawn from the reference tables in the 2005 OPTN/SRTR
Annual Report. Please see the article ‘Analytical Meth-
ods and Database Design: Implications for Transplant Re-
searchers, 2005’ in this report for an explanation of the
methods of data collection, organization and analysis that
serve as the basis for this article (1). Additional detail on
the methods of analysis employed herein may be found in
the reference tables themselves or in the technical notes
of the OPTN/SRTR Annual Report, both available online at
http://www.ustransplant.org.
Organ Donation: OPO to DSA
The United States is served by 58 organ procurement or-
ganizations (OPOs), entities that are designated by the
Centers for Medicare and Medicaid Services (CMS) to
provide donor services within defined geographic areas.
Prior to the collaborative, the success of a region’s organ
donation services was considered the responsibility of its
OPOs. With the collaborative came the recognition that
successful organ donation is the joint responsibility of the
OPO, its geographically proximate transplant center(s), and
the donor hospitals that it services in the region. These
three entities constitute a donation service area (DSA);
each component plays a key role in the donation process.
OPOs are responsible for providing state-of-the-art com-
munity and hospital donor education, donor management
services, stewardship of the donated organ and fair and eq-
uitable distribution practices, set in accordance with OPTN
policies. Transplant centers are responsible for providing
state-of-the-art management, consultant and procurement
services, as necessary; centers also must assure opti-
mal utilization of the donated organs. Finally, donor hos-
pitals are responsible for identifying all potential donors
and for facilitating donor assessment, management, test-
ing and organ procurement, as needed. Together, the 58 na-
tional DSAs define the U.S. working transplant community
(Figure 1).
The Organ Donation Breakthrough
Collaborative
Overview of the collaborative
To fully appreciate the forces currently driving organ dona-
tion, it is necessary to have a working understanding of the
collaborative process. The collaborative methodology was
developed by the Institute for Healthcare Improvement in
the early 1990s (2). The purpose of a collaborative is to
facilitate breakthrough changes in the performance of or-
ganizations, based on their adoption of proven practices
from top performers in the field. Specifically, the aim of
the Organ Donation Breakthrough Collaborative is to save
or enhance thousands of lives a year by spreading known
Figure 1: Donation service areas in the United States, 2005.
best practices of organ donation to a group of the nation’s
hospitals with the greatest potential for organ donation.
The goal established for the initiative was to achieve organ
donation rates of 75% or higher in these hospitals. This goal
was not arbitrary. It was chosen as ambitious, yet within
the reach of the highest performers in the field. Further-
more, this target was not achievable through simple incre-
mental annual change; it required creative, breakthrough
thinking to accomplish. HHS and key leaders from national
health care organizations, including the Association of Or-
gan Procurement Organizations, the Joint Commission on
the Accreditation of Healthcare Organizations and the In-
stitute for Healthcare Improvement, publicly committed to
the goal.
Breakthrough methodology
According to the methodology of the collaborative (2), ex-
pert faculty members are chosen, teams from the institu-
tions of interest are established, and strategies to achieve
the targeted goal are developed by the participants. These
strategies are then put into practice, tested and modified, if
necessary. Finally, successful practices are spread to other
institutions. This last step is key to the collaborative pro-
cess, as it makes possible immediate improvement for ev-
ery participant involved.
Team formation
Two Organ Donation Breakthrough collaboratives have
been conducted to date, and a third began in October
2005. Collaborative 1 ran from September 2003 through
September 2004. This event targeted the 300 hospitals
in the nation with the greatest potential for donation.
Team members came from 95 of the 300 donor hospi-
tals and the 43 OPOs affiliated with them. Collaborative
2 ran from September 2004 through May 2005. The cross-
organizational teams for this collaborative included partici-
pants from 131 of the nation’s 500 largest hospitals and the
50 OPOs affiliated with them. Collaborative 3 ascribes the
new goal of improving ‘yield’ (the number of organs pro-
cured and transplanted) from each donor and brings trans-
plant centers more fully into the process.













































































Source: Organ Donation Breakthrough Collaborative. 
Figure 2: Cumulative increase/decrease in deceased donors
in collaborative versus non-collaborative hospitals, by month.
Results of the first collaboratives
Ultimately, of the 552 largest U.S. hospitals collectively tar-
geted by the first two collaboratives, 184 met and sus-
tained the goal of a 75% conversion rate for a period of
12 months. (The conversion rate, also called donation rate,
is calculated as the number of actual donors age 70 years
or younger from whom at least one organ is recovered for
the purpose of transplant divided by the total number of
eligible deaths.) During the timeframe of the first collabora-
tive, participating hospitals achieved a 14% increase in the
number of deceased donors, compared with their own per-
formances for the same period the prior year. The increase
for hospitals not in the collaborative was 8% (Figure 2).
It is noteworthy that non-participating hospitals saw an 8%
increase in donors over the prior year. This increase, which
was far in excess of increases in previous years, was con-
sistent with the anticipated result of the spread of success-
ful practices to donor hospitals by the OPOs that worked
within the collaborative.
Trends in Organ Donation
OPO/DSA donor activity
Overall, the trend in OPO recovery data was upward over
the past 10 years. When comparing the most recent
3 years of data, 24 OPOs (41%) had 2 consecutive years
of growth. Only five (8%) had 2 consecutive years of de-
cline (Table 1). The high percentage of OPOs experiencing
consecutive years of growth suggests that the increase
nationally in both the number of deceased organ donors
and organs transplanted from deceased donors is a broad-
based trend; this is indicative of a healthy organ procure-
ment system with good prospects for further growth.
Consent
Important strides in improving the consent rate were made
during the past 10 years. The conversion rate for donors
was 40% in 2001, the first year this statistic was recorded.
Table 1: Growth and decline in OPO recovery, 2003–2004
Number Percentage
Pattern of recovery of OPOs of total
Two consecutive years of growth 24 41%
Two consecutive years of decline 5 8%
Growth in 2003 and decline in 2004 12 20%
Decline in 2003 and growth in 2004 14 24%
Growth in 2003 and no change in 2004 1 2%
No change in 2003 and decline in 2004 1 2%
No change in 2003 and growth in 2004 2 3%
Total 59 100%
Source: SRTR analysis, August 2005.
From 2002 to 2003, the conversion rate increased by
1.6%, and in 2004, it increased by 4.6%. For the first
4 months of 2005, the conversion rate is up 5.2% over 2003
(Table 2). Of particular interest were best practices identi-
fied by the collaborative that targeted specific impediments
to consent, including minority participation and approach to
the family.
Minority participation: Historically, minority consent
rates have lagged behind those of the general population.
Though there have been varying approaches and view-
points over the years, best practices aimed at providing
consent requestors of racial/ethnic backgrounds matched
to those of the potential donor family have evolved in the
last decade and are generally well accepted as addressing
the issue of minority consent. Likewise, trained requestors
speaking various languages other than English, most no-
tably Spanish, have been employed to reach out to non-
English speaking families (3–6).
Decoupling: Those analyzing best practice strategies
have focused attention on the timing of requests to the
families of potential donors. The technique of ‘decoupling’
for many years was considered optimal. This strategy en-
tails separate conversations with the family, first informing
family members of the patient’s death and only later mak-
ing the request for donation, a request often presented
by a different person. In other words, the family would be
notified of the death by a physician, who would explain
and answer questions about the diagnosis of brain death.
Following a time lapse, another individual or group of indi-
viduals would request permission for organ donation. This
timing was considered successful by most, though not all,
throughout much of the last decade or more (7–9). More
recently, timing started to be addressed under the umbrella
of so-called ‘appropriately timed’ requests. Instead of con-
sidering that the best time for approach would always be
after a discussion of death and always after a time lapse,
it was recognized that a better time to discuss donation
is when a family is ready to make end-of-life decisions, a
time that varies widely from one family to the next. In some
cases, the discussion of donation options, including dona-
tion after cardiac death (DCD), occurs well before poten-
tial donors have reached brain death (if, indeed, they ever
do). What is key are the actions and statements by family
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Table 2: Reported eligible deaths, actual donors, and conversion rate August 2001–April 2005
August–December January–April
2001 2002 2003 2004 2005
Actual donors ≤ 70 years 2397 5746 5911 6448 2204
Reported eligible deaths 6021 11419 11394 11420 3856
Conversion rate 39.8% 50.3% 51.9% 56.5% 57.2%
Source: Organ Donation Breakthrough Collaborative.
Conversion rate = Actual donors ≤70 years/reported eligible deaths.
members, which indicate their readiness to have a conver-
sation about end-of-life issues, including donation.
Team design: During the past decade, the approach to
the family has evolved into a shared responsibility between
OPO staff, hospital staff (nurses, physicians and others)
and members of the clergy. This cooperative group pro-
vides a flexible team that is better able than a single person
to address the varying needs of individual families. As with
the approach to timing a donation request, each family is
unique in terms of those with whom members feel com-
fortable and those to whom they reach out for assistance.
A key concept that has evolved, which is additive to such
strategies as appropriately timed requests and increased
sensitivity regarding minority participation, is that of the
‘team huddle’. In this approach, team members determine
a strategy they feel best meets the needs of the potential
donor family. This huddle allows for presentation of mul-
tiple points of view and sharing of expertise; it serves as
a way to enlighten all participants regarding the nuances
of the particular family situation. While it would be difficult
to impossible to say what impact each of these strategies
has had on the national consent rate, it is reasonable to
say that together they have contributed significantly to its
improvement.
The importance of consent: When individuals referred
by hospitals as potential donors fail to become actual
donors, the reasons fall into four categories: lack of med-
ical suitability, non-referral, logistical/legal issues and no
consent. Lack of medical suitability is straightforward; it
removes a death from the potential donor pool. As for non-
referral, laws that require the timely reporting of all po-
tential donors are now in place. In fact, ‘conditions of par-
ticipation’, issued by CMS, went into effect in 1998 and
ensure that only those hospitals that refer potential donors
in a timely fashion to their contracted OPO remain eligible
to receive Medicare benefits (10). However, simple refer-
ral in the absence of effective consent will not increase
donation. And, while important, logistical and legal issues
seem far less likely to preclude donation than nonconsent.
Therefore, it is reasonable to assign much of the success
in increased conversion rates following the collaborative to
strategies that addressed and raised consent rates.
Through the collaborative process, the strategies dis-
cussed above took many practical forms, some of which
Table 3: Refusal codes for withholding consent to donate, 2004
Code Reason Number of cases
100 Emotional 20,562 (56.5%)
101 Cultural beliefs 431 (1.19%)
102 Religious beliefs 198 (0.54%)
103 Family conflict 1249 (3.43%)
199 Other specify 13,930 (38.3%)
Source: Organ Donation Breakthrough Collaborative.
will undoubtedly be reported in the literature for months
and years to come. However, data that accurately reflect
the reasons for declining consent are necessary in order to
design programs that effectively address issues that dis-
courage some population groups from consenting to do-
nate (11,12). Unfortunately, data regarding reasons for de-
clining consent are sketchy. Currently available ‘turn down
codes’ used to classify the reason that consent for dona-
tion was denied are presented in Table 3. Unfortunately,
this group of codes is so general in nature as to provide
little insight. Of the 36 000 turn down codes recorded over
the years, 57% were due to ‘emotional’ reasons and 39%
were due to ‘other’. Given that tens of thousands of po-
tential organs were lost because of lack of consent, the
revision of these codes should have a high priority.
Deceased Organ Donation
Prior reviews documented a 2%–4% increase per year in
deceased organ donation between 1995 and 2003 (13). In
2004, deceased donation increased 11% over 2003, (7152
donors up from 6457). Compared with 1995, organ dona-
tion in 2004 increased by 33%. Increased organ donation
was noted for all organs, with the exception of the heart.
Heart donation decreased in 9 of the previous 10 years.
The exact cause for this is unclear. Although the deceased
donor population continues to age, this may not be a sig-
nificant factor. While the average age of deceased donors
increased steadily from 34.2 years in 1995 to 39.8 years
in 2004, with the percentage of donors aged 50–64 years
increasing from 19% of donors in 1995 to 25% in 2004
(SRTR analysis, May 1, 2005), the age distribution of heart
donors remained flat for all age levels throughout the entire
10-year period.
The number of deaths due to trauma decreased slightly
in 2004 compared with 2003 (39.1% from 40.5%).
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For kidney, any deceased donor over the age
of 60 years; or from a donor over the age of
50 years with two of the following: a history
of hypertension, a terminal serum creatinine
>1.5 mg/dL, or death resulting from a




Donation of any organ from a patient whose
heart has irreversibly stopped beating.
Includes donors who also qualify as ECD
under the kidney definition above
Standard criteria
donors (SCD)
For kidney, a deceased donor who is neither
ECD nor DCD. These donors often have
fewer risks associated with graft failure
Source: 2004 OPTN/SRTR Annual Report.
Because organs from trauma victims tend to function well,
even a modest decrease in deaths due to head trauma is
a concern. It appears this decrease is partly due to a slight
increase in the number of deaths due to anoxia, which
is more damaging to organs, and which has been trend-
ing upward (14% from 11% five years previously). How-
ever, there are no trends apparent in the circumstances
and mechanisms of death data that bear out a major
change.
Demographics generally have been stable otherwise, in-
cluding the interesting differences in distribution of the
sexes, which is reproducible year after year (female to male
about 42%–58% for kidney, lung and liver, but 34–66% for
heart and pancreas). The reason for this difference in donor
ratios between the sexes for the different organs is not in-
tuitively obvious.
The absolute number of standard criteria donors (SCD)
for kidney increased almost proportionally with the over-
all trend in donation, although the fraction of SCD donors
compared with the total was slightly lower in 2004 com-
pared with 2003 (74% of 4678 donors compared with 75%
of 4329 donors). Note that SCD kidneys exclude expanded
criteria donors (ECD), DCD and DCD/ECD donors (Table 4).
The decreased percentage of SCD compared with the total
donor population appears to be due mainly to the increase
in DCD (5% up from 4%).
Nationally, minorities participated fully in the remarkable in-
crease in deceased donation noted in 2004 compared with
the prior 9 years. In 2004, there were 1008 African Amer-
ican donors up from 893 in the prior year, and 950 His-
panic/Latino donors up from 822 donors the year before.
These increases calculate to 13% and 16%, respectively,
as compared with the 11% national increase.
The data indicate there may have been opportunities to
increase the number of organs donated from existing de-
ceased donors. In 2004, there were only 17 donors pro-
viding pancreas and kidney only, since such donors would
be likely to have other organs donated as well. However,
there were 747 combined pancreas-liver-only or pancreas-
intestine-only donors. It is worth examining how so many
donors were qualified to provide liver and pancreas but not
kidneys. Although in some cases an older donor would be
considered for liver but not kidney donation, these donors
that include pancreas should not be in that group, since
older age is a relative contraindication for using the pan-
creas. Some of these cases may have been due to intrinsic
chronic renal disease in the donor, but the incidence of this
would not explain the large number that were not kidney
donors (14–16). Equally striking is the observation that only
89% of all donors were kidney donors.
Another possible opportunity regards pancreas donors.
There were 3556 donors consented for pancreas in which
the organ was not recovered. Of these, in 685 instances
the reason was ‘Donor Medical/Social History’. This con-
trasts with kidney, for which there were only 1240 donors
consented with no kidney recovered; of these, 247 were
due to ‘Donor Medical/Social History’. ‘Hepatitis/HIV/HTLV-
1’ and ‘Poor Organ Function/Infection’, both alternate cat-
egories, were not the dominant reasons for nonrecovery.
Thus, it appears that for a substantial number of donors un-
der consideration for kidney and pancreas recovery, ‘Donor
Medical/Social History’ was reported as an exclusion rea-
son for recovery of the pancreas but not the kidneys.
These observations reflect the overall national statistics,
making it difficult if not impossible to determine if they are
universally valid. Additional opportunities for donation may
be present in specific DSAs based on differences in DSA
practices. Exploring differences between DSA practices in
an attempt to identify additional opportunities for organ
procurement and transplantation is a major task of the next
collaborative.
ECD donation
Candidates on the general list for kidney transplantation
may choose to be added to the ECD list for kidneys. In
2004, ECD kidney donors numbered 1341 (1278 ECD-only
and 63 ECD/DCD combined); this is 21% of all kidney
donors. However, as mentioned above, the current def-
inition of ECD is specific to kidney; expanded criteria or
any other guidelines for evaluating the other solid organs
have yet to be generally accepted. Given this lack of defi-
nition for ‘marginal’ or ‘expanded criteria’ livers, pancreata,
hearts and lungs, the impact of using ‘less standard’ organs
on other donor pools is unclear.
Recently, a number of groups, including a New York State
Task Force, attempted to define the ECD liver donor by
identifying those donor characteristics that lead to a rela-
tive risk of graft failure of 1.7 times higher than expected.
These criteria were similar to those used to define ECD kid-
ney donor (17). In their analysis, they found that increasing
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donor age, DCD, split donor liver and some donor causes of
death (e.g., cerebral-vascular accident, central nervous sys-
tem tumor or drug overdose) were associated with poorer
outcomes for liver. New work by the SRTR is refining these
findings to develop a continuous scale of donor quality (18).
Thus, the characteristics that define an ECD kidney donor
and an ECD liver donor are different. It is, therefore, pos-
sible that a given donor may donate SCD kidneys but also
an ECD liver.
Since characteristics associated with higher relative risk of
allograft failure differ for one organ compared with another,
even from the same donor, the concept of the ECD dona-
tion may be labeled more specifically as expanded crite-
ria ‘organ’ donation: for example, expanded criteria kidney
(ECK), expanded criteria liver (ECL), and so on.
Donation after cardiac death
As the number of deceased organ donors grew over the
last decade, there was a concurrent increase in DCD. Be-
tween 1995 and 2004, the number of donors providing
organs after cardiac death increased more than sixfold,
from 64 to 391, a much steeper rate of increase than for
donors providing organs after brain death. Some of the
overall increase in deceased donor numbers was due to
these rapidly increasing instances of DCD. If one removes
the DCD from the deceased donor data, the increase from
1995 to 2004 is reduced from 33% to 28%. Although DCD
makes up a relatively small fraction of the national per-
centage of deceased donors (5% in 2004), the full po-
tential for DCD to expand the national deceased organ
donor pool is best appreciated by the fact that only seven
DSAs accounted for 58% of all instances of DCD, and, in
these DSAs, DCD accounted for 17%–20% of their donors
(Figure 3). In summary, DCD represents a small (5%) sub-
set of all deceased donors, but it has the potential to sub-
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Source: SRTR Analysis, May 2005.
1
17 OPOs reported no DCDs 
Figure 3: Number of donations after
cardiac death (DCD), by OPO, 2004.
Table 5: Organs recovered from DCD donors, 2004





Source: 2005 OPTN/SRTR Annual Report, Tables 2.2–2.4, 2.7.
National data on DCD reveal that organs recovered from
DCD in 2004 were predominantly kidneys and livers. DCD
pancreas recovery was 13% (Table 5).
DCD kidney donors: Of the 7152 deceased organ
donors in 2004, 6327 (88%) were kidney donors. This num-
ber is up from 5003 in 1995, an increase of 26%. Among
these 6327 donors, 308 (5%) were instances of DCD. Us-
ing the classification of deceased kidney donors as ‘stan-
dard, ECD or DCD’ (Table 4), 1278 out of the 6327 donors
(20%) met the definition for ECD; 63 donors (1%) met both
ECD and DCD criteria. Nearly 80% of those who donated
after cardiac death (308 DCD/non-ECD of 391) were kidney
donors, somewhat less than the percentage in deceased
donors overall.
DCD pancreas donors: Over the last 10 years, pancre-
ata for transplantation have been almost exclusively recov-
ered from SCD donors. Of the 2021 pancreata procured in
2004, only 49 (2%) were from DCD. This number, though
small, doubled from 22 in 2003. Pancreata were recovered
in 13% (49 of 391) instances of DCD.
DCD liver donors: There were 6321 deceased liver
donors in 2004, representing an increase by 46% since
1995. Of the 6321 donors, 242 (4%) were DCD. Next
to kidney, liver is the most commonly used organ from
DCD, with 62% being liver donors. It is possible that this
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percentage may increase substantially once there is a bet-
ter understanding of the relative risk factors for DCD versus
SCD livers.
DCD lung donors: In 2004, lungs were procured from
1065 deceased donors. Among these were five instances
of DCD, which represents an increase from 0% in 1996 to
0.5% in 2004. The first lung DCD took place in 1997; a sec-
ond did not occur until 2001. In the following years, one,
three and five lung donations occurred following cardiac
death. For the five instances of DCD for lung in 2004, both
lungs were retrieved. The potential for DCD to add signifi-
cantly to the lung donor pool will depend on the outcomes
observed from this initial experience.
DCD intestine donors: Only 166 (2%) of all deceased
donors in the United States in 2004 were intestine donors
and none were DCD. This likely reflects the relatively small
demand for intestinal allografts compared with other or-
gans and/or a poor understanding of the characteristics that
predict short- and long-term outcomes for DCD intestinal
allografts.
Utilization of DCD organs: As seen above, recovery
of DCD organs increased rapidly over the past 10 years.
Kidney was the first organ to be routinely recovered fol-
lowing cardiac death, and kidney utilization from DCD
has remained relatively stable at about 1.6 kidneys trans-
planted per DCD donor. Utilization of livers has been in-
creasing, with livers transplanted per instance of DCD in-
creasing from 0.33 in 2000 to 0.47 in 2004 (Figure 4).
More recently, lungs have been successfully procured for
transplantation from DCD, a trend that is likely to con-
tinue. Functional outcomes of organs from these donors
in terms of short- and long-term survival will necessar-
ily be the subject of close evaluation and will deter-
mine the potential for DCD to add significantly to the de-







































Source: 2005 OPTN/SRTR Annual Report, Tables 2.12, 2.13, 2.14. 
Figure 4: Organs transplanted per DCD donor by organ type,
1995–2004.
Table 6: Utilization of DCD organs, 2004
Number of DCD individuals ORPD∗ OTPD∗∗
Kidney (n = 371) 1.88 1.45
Pancreas (n = 49) 0.13 0.07
Liver (n = 242) 0.62 0.47
Lung (n = 5) 0.03 0.03
Source: 2005 OPTN/SRTR Annual Report, Tables 2.12–2.14, 2.17.
∗Organs recovered per donor.
∗∗Organs transplanted per donor.
to donor characteristics. The number of organs procured
and transplanted per donor after DCD are summarized in
Table 6.
Implications of current ECD and DCD practices
Economic considerations: ECD and DCD organs have
potential cost implications for both organ procurement and
transplantation. As experience with ECD and DCD has
grown over the past 10 years, two trends have become
apparent. First, the number of liver-only donors has risen
from 320 in 2000 nationally to 655 in 2004, a growth from
5% to 9% (Table 7). These instances of donation incur
nearly all the cost of a multi-organ donor if other organs
are thoroughly evaluated but ultimately not recovered, yet
provide only one organ from which to recover the cost
through a standard acquisition charge (SAC). Depending
upon whether kidneys are recovered but not transplanted,
whether the intent is to recover other organs or not, and
how the CMS intermediary interprets each donor case and
directs the OPO to assign cost, overhead costs not recov-
ered from organ SACs may make their way into the var-
ious cost centers and may, eventually, lead to increased
organ SAC rates. At the very least, the increase in liver-
only donors will drive up liver SACs; the effect on other
organs is less clear but bears further study.
Second, the number of kidneys undergoing pulsatile per-
fusion (PP) has nearly doubled, from 1464 in 2000 to
2780 in 2004, or from 13% of all deceased donor kidneys
in 2000 to 22% in 2004 (Table 8). While this technique,
which circulates a preservation solution through the organ
rather than packing it in an iced solution, is more effec-
tive than static storage—especially for organs that may be
compromised—it represents a significant additional cost
when compared with non-PP cold storage (19). Capital
equipment (pumps), disposable supplies (cassettes) and
the effort required to perform PP are all additional costs
not incurred with cold storage and are costs that find their
way into the renal SAC.
These trends and similar developments, which will be-
come apparent as instances of ECD and DCD continue
to rise, are worth further study. A thorough cost and out-
come analysis of ECD, DCD and SCD as they compare with
each other is necessary if we are to fully understand the
implications of increased use of these donors.
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Table 7: Trends in liver-only donors, 1995–2004
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Total deceased donors 5363 5418 5479 5793 5824 5985 6080 6190 6457 7152
Total non-kidney donors 360 380 395 454 438 496 552 552 703 825
Liver-only donors 164 205 216 273 275 320 378 382 532 655
% Liver-only to total donors 3.1 3.8 3.9 4.7 4.7 5.3 6.2 6.2 8.2 9.2
Source: SRTR Analysis, June 2005.
Table 8: Frequency (%) of pumped kidneys, 1995–2004
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Total kidneys recovered 9937 10020 10091 10594 10703 10909 10986 11196 11437 12575
Pumped kidneys 1526 1618 1530 1556 1267 1464 1666 1816 2133 2780
% Kidneys pumped 15.4 16.1 15.2 14.7 11.8 13.4 15.2 16.2 18.6 22.1


















































Source: SRTR Analysis, April 2005.
Figure 5: Kidney delayed graft function by deceased donor
type, 2000–2004.
Potential impact of DCD and ECD donation: While
ECD and DCD appear to have significantly increased the
number of donated organs, it is apparent that these prac-
tices increase the cost of organ donation. It also appears
that caring for the recipients of these organs increases the
cost of caring for organ transplant recipients. For exam-
ple, the national reported rate for delayed graft function,
which creates the need for at least one dialysis session
after transplantation, was 23% for SCD kidney allografts
but 38% for ECD kidneys and 43% for DCD kidneys in
2000–2004 (Figure 5).
There can be little doubt of the added clinical benefits that
can be achieved by ECD and DCD donation. However, it is
important to recognize the potential for procurement and
transplantation of organs from these types of donors to
increase SACs and recipient costs. As increased costs for
procurement and transplantation have the potential to neg-
atively affect organ donation services and organ transplan-
tation, accurate tracking of cost data specifically related
to ECD and DCD should have a high priority. The infor-
mation to be gained will help the DSA community work
with the CMS and third party carriers to assure that reim-
bursement for ECD and DCD donation and transplantation
is adequate.
Living Donation
Increased public awareness of the organ donor shortage is
demonstrated by the year-to-year increase in the number of
organs donated by living donors between 1995 and 2004.
Over the past 10 years, the number of donated organs
increased from 3493 to 7002. In fact, from 2001 to 2003,
the number of living organ donors surpassed the number
of deceased donors.
Living kidney donation
Kidney donation by living donors has increased steadily by
approximately 200 donors per year for the last 3 years.
As in prior years, the majority of living kidney donors
were female (58% in 2004). Several characteristics of the
donor population have changed significantly over the last
10 years. In 1995, parents and full siblings made up two-
thirds of the living donor population; in 2004, this figure had
dropped to only one-third. The largest increase was in the
‘other unrelated’ category of donor, which increased from
5% to 21%. This category does not include spousal donors,
who increased from 8% to 12%. In addition, 212 or 3% of
the living kidney donor population in 2004 are listed in the
2005 OPTN/SRTR Annual Report as having an ‘unknown’
relationship. The reason for this is unclear. The number of
donors of ‘unknown age’ also increased in this year’s report
to 73 (1%), from one or two in most of the previous years.
Regardless, over the past 10 years the majority of living
donors have shifted from related to unrelated. It seems
likely that at least part of this trend has occurred as the
result of the increased use of laparoscopic donor nephrec-
tomy, which is less invasive than major surgery. Further-
more, increased public awareness encourages transplant
centers to freely discuss donation with all potential donors.
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Source: 2005 OPTN/SRTR Annual Report, Table 2.9.
Figure 6: Living kidney donor ethnicity, 1995–2004.
The present living kidney donor population is older than
in 1995; in that year, 559 of 3392 (16%) were of age 50
years or more. In 2004, the same group comprised 1368
of 6,645 (21%) of the donors. This is probably due to the
general aging of the population and the more proactive
position of transplant centers and recipients on using kid-
neys from older donors. The racial composition of the liv-
ing kidney donor population has not changed significantly
since 1995. About 70% of these donors are white, al-
most exactly the same percentage as in deceased donors
(Figure 6). There were no living pancreas transplants re-
ported in the United States in 2004; the numbers in this
category have exceeded 10 for the entire country only once
in the last 10 years.
Living liver donation
The number of living liver donor transplants increased from
54 in 1995 to 92 in 1998. In 1999, however, there was a
quantum step up in the number of living liver donors, grow-
ing to 253 donors, a 175% increase over the prior year. This
increase was primarily due to adult-to-adult liver transplan-
tation. The absolute number of living liver donors peaked at
518 in 2001 and has remained stable at approximately 320
for the past few years. The future potential for growth in
adult-to-adult living donor liver transplantation will depend
on short and longer term outcomes data.
In 2004, 87% of living liver donors were under age 50 years.
In 1995, 93% of these donors were parents of recipients,
presumably mostly children. By 2004, however, the per-
centage of parental donors had fallen to 14%, with off-
spring making up 26% and other unrelated persons 22%
of total living liver donors (Figure 7).
Living lung donation
Only 28 living lung cases were performed in the United
States in 2004. This number has been flat since 2002, hav-
ing declined from its peak of 58 in 1999. Even among this
































Source: SRTR Analysis, May 2005.
Figure 7: Comparison of adult-to-adult and adult-to-pediatric
living liver transplants, 1995–2004.
gorized as ‘other unrelated’ has increased, from 5 of 45 in
1995 to 11 of 28 in 2004.
Living non-directed donation
Living non-directed donation is a phenomenon of the last
5 years. Of the 297 living non-directed donations reported
for the last 10 years, only seven occurred between 1995
and 1999. Of the 290 donors reported from 2000 to 2004,
175 (60%) occurred in 2003 and 2004 (Table 9). Participants
from centers actively involved in living non-directed dona-
tion recently met at a symposium focused on this topic.
There was general consensus that the growing number
of living non-directed donors results from two factors: (1)
increasing public awareness of the organ donor shortage,
and (2) a new willingness on the part of transplant centers
and OPOs to participate in these cases. No best methods
for donor evaluation, organ distribution or donor follow-up
were identified as forthcoming. But it was the unanimous
consensus of the conference that the members of the
transplant community who participate in this type of do-
nation have a heightened level of responsibility to assure
the well being of these individuals (Personal communica-
tion: Toward Understanding Living non-Directed Donation.
Seattle, October 2004).
In summary, living organ donation continues to increase,
driven almost entirely by increases in kidney donors. These
donors are somewhat older and definitely less closely re-
lated than they were 10 years ago.
Summary
Improved rates of organ donation are essential to respond
to increasingly large waiting lists and to take advantage
of continuing advancements in organ transplantation. The
Organ Donation Breakthrough Collaborative, which began
its work in September 2003, is demonstrably successful
in its efforts to identify and disseminate organ donation
best practices. By building on the partnership inherent in
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Table 9: Living unrelated and non-directed donation, 1995–2004
1995 1996 1997 1998 1999 2000 2001 2002 2003 2004
Total living donors 3493 3790 4059 4568 5037 5928 6606 6629 6826 7002
Living unrelated donors∗ 421 580 664 929 1112 1542 1835 1993 2231 2352
Non-directed donation 0 0 0 2 5 21 35 59 87 88
Source: SRTR Analysis, June 2005.
∗Does not include living/deceased exchange.
the concept of the DSA, the collaborative has challenged
OPOs, transplant centers and donor hospitals to identify,
improve and share their most effective strategies for con-
verting eligible deaths to transplanted organs. Deceased
donation increased 11% in 2004 over 2003 to 7152 donors;
much of this improvement may well be traced to the efforts
of the collaborative.
The concepts of ECD and DCD are further expanding de-
ceased donor organ availability, though many questions re-
main to be answered about the impact of these less stan-
dard organs on transplantation and outcomes. While both
ECD and DCD clearly are producing increased numbers
of organs, they raise problematic issues of increased cost
and complexity. Efforts must be ongoing in the transplant
community to track costs associated with delayed graft
function and nonprocurement of consented organs. Work
must also continue on the development of organ-specific
definitions of expanded criteria organs besides kidney. This
is best accomplished by studying factors associated with
higher relative risk of allograft failure by type of organ, rec-
ognizing that factors may differ, so that one donor could
yield both ECD and non-ECD organs. Finally, living donation
continues to make strides, as the number of such organs
increased from 3493 in 1995 to 7002 in 2004. Changes in
the makeup of the living donor population, including more
unrelated donors and those who provide non-directed do-
nations, demand continued study.
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